Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of bimatoprost in vitiligo
TCTR20170526002Phase 4Recruiting
- Sponsor
- Siriraj Hospital
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in Vitiligo, sponsored by Siriraj Hospital. Started Mar 2017; status: recruiting.
02
Drugs
bimatoprost
03
Conditions
Vitiligo
Beyond the preview
Go deeper on TCTR20170526002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170526002.